Oxibendazole: critical anthelmintic trials in equids.

The research article discusses the evaluation of oxibendazole’s effectiveness as an anthelmintic (worm-killing) agent in horses. Single oral doses of varying amounts were given to naturally infected ponies, with the results indicating strong efficacy against certain gastrointestinal parasites but less activity against others.

Efficacy of Oxibendazole

• The article outlines that the researchers conducted a clinical trial of oxibendazole, a drug used to treat gastrointestinal parasite infestations in horses, using the critical test method. This involves administering the drug to naturally infected animals and then assessing its efficacy based on parasite counts.
• Single oral doses of 5, 10, or 15 mg per kilogram of body weight were administered to the ponies. The tested dosages showed no apparent dose-related differences in effectiveness, implying that even at smaller doses, the drug was still highly effective.

Effectiveness Against Various Parasites

• Oxibendazole was found to be highly effective against large and small adult strongylids, especially species of the genera Cylicostephanus, Cylicocyclus, Cyaathostomum, and Triodontophorus. Strongylids are a type of worm that infests the gastrointestinal system of horses, causing illness.
• It was also highly effective against adult and larval stages of the large pinworm, Oxyuris equi, a common parasite in horses whose infestation can cause rectal itching and other signs of discomfort.
• In contrast, oxibendazole was less effective against fourth-stage small strongylid larvae compared to adults, indicating that its efficacy may depend on the lifecycle stage of the parasite.

Lack of Activity Against Other Parasites

• The drug showed no activity against a range of other parasites, including stomach bots (Gasterophilus spp), tapeworms (Anoplocephala magna and A perfoliata), lungworms (Dictyocaulus arnfieldi), abdominal worms (Setaria equina), and mature or immature nematodes outside of the gastrointestinal tract. This suggests the drug’s effectiveness is specific to certain types of gastrointestinal worms.